 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
Relative Risk of Estrogen-Related Side Effects
|
35 µg EE OC vs. Two 20 µg EE OCs
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
Relative Risk of
|
|
|
35 vs. 20 g EE OCs
|
|
(Ortho Tri-Cyclen vs.
|
|
Side
Effect Alesse and Mircette)
|
|
|
Breast
tenderness 1.5*
|
|
|
Nausea 1.6*
|
|
|
Bloating 1.4*
|
|
|
*P<.05.
|
|
|
|
|
|
|
|
|
Rosenberg MJ et al. Contraception.
1999;60:321-329.
|
|
|
|
|
 |
|
|